Related Experiment Video
Updated: May 24, 2025

06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
7.2K
The research progress on meningeal metastasis in solid tumors
Yi Yue1, Yuqing Ren1, Chunya Lu1
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Discover Oncology
|February 28, 2025
Summary
Leptomeningeal metastases (LM) are a fatal stage of solid tumors with rising incidence. Early diagnosis and novel treatments are crucial for improving patient survival and addressing this significant health challenge.
Area of Science:
- Oncology
- Neurology
- Pathology
Background:
- Meningeal metastasis (MM), specifically Leptomeningeal metastases (LM), signifies an advanced, life-threatening stage of solid tumors.
- LM presents a substantial societal and patient burden, with increasing annual incidence.
- Current diagnostic and therapeutic approaches for LM face limitations, including low efficiency and suboptimal outcomes.
Purpose of the Study:
- To provide a comprehensive review of recent advancements in meningeal metastasis (MM) research in solid tumors.
- To elucidate the underlying mechanisms driving MM development.
- To explore diagnostic and prognostic biomarkers for MM and address current research challenges.
Main Methods:
- Literature review of recent research on meningeal metastasis (MM) in solid tumors.
- Analysis of studies focusing on MM mechanisms, biomarkers, and treatment strategies.
- Synthesis of findings to identify research gaps and future directions.
Main Results:
- Recent research has made progress in understanding MM mechanisms, though significant challenges remain.
- Identification of potential diagnostic and prognostic biomarkers is an active area of investigation.
- The lack of standardized treatment protocols highlights the need for further therapeutic development.
Conclusions:
- Early recognition and intervention are critical for improving survival in patients with LM.
- Further research is essential to overcome diagnostic limitations and develop effective, standardized treatments for MM.
- Elucidating MM mechanisms is key to advancing management strategies for this advanced cancer complication.

